Status:
COMPLETED
Predicting Outcomes for Covid-19 Using Sonography
Lead Sponsor:
Stanford University
Conditions:
COVID-19
Pneumonia, Viral
Eligibility:
All Genders
18+ years
Brief Summary
This study seeks to investigate the role of lung ultrasound in caring for Covid-19 positive patients and whether it can be used to predict patient deterioration. This information will be vital for hea...
Detailed Description
As Covid-19 continues to stress hospital-based resources (including personal protective equipment, ancillary staff availability, and imaging study utilization), it is important to assess whether alter...
Eligibility Criteria
Inclusion
- Any adult (18 or more years of age) presenting to the emergency department with symptoms suspicious for Covid-19
- This individual underwent evaluation for Covid-19 via a nasopharyngeal RT-PCR
- This individual received a lung ultrasound by the study authors within 28 days from initial evaluation
Exclusion
- Any individual who did not receive a lung ultrasound within 28 days from initial evaluation for covid-19 related illness
Key Trial Info
Start Date :
March 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 15 2021
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT04384055
Start Date
March 21 2020
End Date
November 15 2021
Last Update
December 3 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California San Francisco
San Francisco, California, United States, 94117
2
Stanford University
Stanford, California, United States, 95401